Funding for this research was provided by:
National Medical Research Council (NMRC/TCR/009-NUH/2013)
Text and Data Mining valid from 2018-08-16
Received: 1 February 2018
Accepted: 6 July 2018
First Online: 16 August 2018
: E.B and S.S are employees and stockholders of Karyopharm Therapeutics. The remaining authors have no competitive financial or non-financial interests.